Hemophilia Center of Western New York — Buffalo, New York

Hemophilia Center of Western New York is a clinical research site located in Buffalo, New York, United States 14209.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Hemophilia Center of Western New York has participated in 5 clinical trials.

Therapeutic areas: Hemophilia B, Blood Coagulation Disorders, Inherited, Blood Coagulation Disorder.

Sponsors: Spur Therapeutics, Genzyme, a Sanofi Company, Bayer.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hemophilia Center of Western New York?

Hemophilia Center of Western New York has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hemophilia Center of Western New York conducted?

Hemophilia Center of Western New York has 5 clinical trials on record. Their work covers Hemophilia B, Blood Coagulation Disorders, Inherited, Blood Coagulation Disorder.

Is Hemophilia Center of Western New York accredited by Crixeo Health?

Yes — Hemophilia Center of Western New York holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Hemophilia Center of Western New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.